SGLT inhibitors in cancer therapy

Just another WordPress site

(32),(15)Brown et al

(32),(15)Brown et al. small conduits are variable depending upon many factors, including the epitope, the nature of the antigen, the source of the antigen, and the identity of the antigen-presenting cell. Keywords:antigen processing, antigen demonstration, MHC class II, alternative processing,…

In addition, individual paraffin sections with 4 human breast cancer cell lines (0, 1+, 2+ and 3+ intensity, provided by Leica), were taken along as controls to validate staining runs. methods were assessable and conclusive (81.8% of cases). Significant variance…

In addition, we speculate on how the BH4 domain of Bcl-2 can be targeted therapeutically not only for diseases associated with apoptosis resistance, but also for diseases associated with accelerated cell death. Keywords:Bcl-2; BH4; inositol 1,4,5-trisphosphate receptor; IP3R; calcium; apoptosis;…

Back to top